Pleural Small Cell Lung Carcinoma: An Unusual Culprit in Pleural Effusion

被引:2
作者
Adejorin, Oluwaseyi D. [1 ]
Sodhi, Amik [1 ]
Hare, Felicia A. [1 ]
Headley, Arthur S. [1 ]
Murillo, Luis C. [1 ]
Kadaria, Dipen [1 ]
机构
[1] Univ Tennessee, Ctr Hlth Sci, Coll Med Memphis, Dept Pulm Crit Care & Sleep Med, Memphis, TN 38163 USA
关键词
Pleural Effusion; Malignant; Small Cell Lung Carcinoma;
D O I
10.12659/AJCR.895276
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Patient: Male, 77 Final Diagnosis: Pleural small cell carcinoma Symptoms: Chest pain . shortness of breath Medication: Clinical Procedure: Thoracocentesis Specialty: Pulmonology Objective: Rare disease Background: Small cell lung carcinoma (SCLC) usually presents as lung or mediastinal lesions. It is very rare for SCLC to present primarily as an isolated pleural effusion with no lung or mediastinal lesions. Case Report: We report the case of a 77-year-old white male with a 60-pack year history of smoking, chronic obstructive pulmonary disease (stage IV), and asbestos exposure who presented with shortness of breath and left lateral chest pain for 7 days. On physical examination, he was very short of breath, with a prolonged expiratory phase on chest auscultation. Laboratory results were normal except for leukocytosis and chest radiograph revealing leftsided pleural effusion. Computerized tomography (CT) scanning of the chest with IV contrast showed left-sided pleural effusion without any lung or mediastinal lesions. Thoracentesis was performed and fluid was sent for analysis. Repeat CT chest/abdomen/pelvis, done immediately following thoracocentesis, did not show any masses or lymphadenopathy. Fluid analysis, including cytology and immunostain pattern, was consistent with small cell carcinoma. Conclusions: Small cell lung cancer presenting as an isolated pleural effusion is extremely rare. It requires close attention to cytology and immunohistochemistry of pleural fluid samples. It also has implications for management and should be managed as limited-stage SCLC.
引用
收藏
页码:912 / 915
页数:4
相关论文
共 17 条
[1]  
Argiris A, 2001, CANCER J, V7, P437
[2]   Should Extrapulmonary Small Cell Cancer Be Managed Like Small Cell Lung Cancer? [J].
Brennan, Sinead M. ;
Gregory, Deborah L. ;
Stillie, Alison ;
Herschtal, Alan ;
Mac Manus, Michael ;
Ball, David L. .
CANCER, 2010, 116 (04) :888-895
[3]   Malignant pleural effusions due to small-cell lung carcinoma: A cytologic and immunocytochemical study [J].
Chhieng, DC ;
Ko, EC ;
Yee, HT ;
Shultz, JJ ;
Dorvault, CC ;
Eltoum, IA .
DIAGNOSTIC CYTOPATHOLOGY, 2001, 25 (06) :356-360
[4]   PRIMARY CARCINOMA OF LUNG - A REVIEW OF 417 HISTOLOGICALLY PROVED CASES [J].
COHEN, S ;
HOSSAIN, SA .
DISEASES OF THE CHEST, 1966, 49 (01) :67-+
[5]   OUTCOME OF PATIENTS WITH SMALL-CELL LUNG-CANCER - EFFECT OF CHANGES IN STAGING PROCEDURES AND IMAGING TECHNOLOGY ON PROGNOSTIC FACTORS OVER 14 YEARS [J].
DEARING, MP ;
STEINBERG, SM ;
PHELPS, R ;
ANDERSON, MJ ;
MULSHINE, JL ;
IHDE, DC ;
JOHNSON, BE .
JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (06) :1042-1049
[6]  
EMERSON GL, 1959, J THORAC SURG, V37, P291
[7]   RANDOMIZED TRIAL OF CYCLOPHOSPHAMIDE, DOXORUBICIN, AND VINCRISTINE VERSUS CISPLATIN AND ETOPOSIDE VERSUS ALTERNATION OF THESE REGIMENS IN SMALL-CELL LUNG-CANCER [J].
FUKUOKA, M ;
FURUSE, K ;
SAIJO, N ;
NISHIWAKI, Y ;
IKEGAMI, H ;
TAMURA, T ;
SHIMOYAMA, M ;
SUEMASU, K .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (12) :855-861
[8]  
JOHNSTON WW, 1985, CANCER, V56, P905, DOI 10.1002/1097-0142(19850815)56:4<905::AID-CNCR2820560435>3.0.CO
[9]  
2-U
[10]  
Kallianos A, 2013, J THORACIC DIS S4, pS420